Influenza, SARS-CoV-2
2 competing products in clinical development for Influenza, SARS-CoV-2.
Pipeline by Phase
Phase 22
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| mRNA-1083 Composition 1 Dose A Lot A | Moderna | Phase 2 | Completed | 0 |
| mRNA-1083 | Moderna | Phase 2 | Completed | 0 |